WYNYARD, UK, May 4, 2022
/PRNewswire/ --
First Quarter 2022 Highlights
- Net loss attributable to Venator of $3
million compared to $21
million in the prior year period
- Adjusted EBITDA of $57 million
compared to $49 million in the prior
year period
- Net cash used in operating activities of $86 million and free cash flow of $(103) million includes a primary working capital
cash use of $87 million attributable
to higher accounts receivables
- Diluted loss per share of $0.03
and adjusted diluted earnings per share of $0.06
- Compared to the fourth quarter of 2021, average TiO2
selling prices increased 12% in local currency, mitigating cost
pressures, and TiO2 sales volumes increased 15%
- Received $85 million cash in
settlement with Tronox on April 25,
2022
|
|
Three months ended
|
|
|
March 31,
|
|
December 31,
2021
|
(In millions, except per share amounts)
|
|
2022
|
|
2021
|
|
Revenues
|
|
$
659
|
|
$
553
|
|
$
535
|
|
|
|
|
|
|
|
Net (loss) income
attributable to Venator
|
|
$ (3)
|
|
$ (21)
|
|
$
14
|
Adjusted net income
(loss) attributable to Venator(1)
|
|
$
6
|
|
$
1
|
|
$
(5)
|
Adjusted
EBITDA(1)
|
|
$ 57
|
|
$ 49
|
|
$
40
|
|
|
|
|
|
|
|
Diluted (loss) earnings
per share (4)
|
|
$
(0.03)
|
|
$
(0.20)
|
|
$
0.13
|
Adjusted diluted
earnings (loss) per share(1)
|
|
$
0.06
|
|
$
0.01
|
|
$
(0.05)
|
|
|
|
|
|
|
|
Net cash (used in)
provided by operating activities
|
|
$ (86)
|
|
$ (15)
|
|
$
17
|
Free cash
flow(3)
|
|
$
(103)
|
|
$ (27)
|
|
$
(9)
|
|
|
|
|
|
|
|
See end of press
release for footnote explanations
|
Venator Materials PLC ("Venator") (NYSE: VNTR) today reported
first quarter 2022 results with revenues of $659 million, net loss attributable to Venator of
$3 million, adjusted net income
attributable to Venator of $6 million
and adjusted EBITDA of $57
million.
Simon Turner, President and
CEO of Venator, commented:
"I am very pleased with our first quarter results, we are
managing inflationary cost pressures well through our customer
tailored price initiatives and cost mitigation actions. Demand for
our products was strong across all our businesses and sectors and
we expect this to continue. We increased production from our TiO2
manufacturing facilities during the first quarter; however,
inventory volumes are at seasonally low levels, which had the
effect of constraining sales volumes.
"On April 25, we successfully
resolved a multi-year legal dispute with Tronox and received
$85 million in cash. We intend to use
a portion of the proceeds to reduce our debt and remain focused on
strengthening our business and positioning Venator for
success."
Segment Analysis for 1Q22 Compared to 1Q21
Titanium Dioxide
The Titanium Dioxide segment
generated revenues of $510 million
for the three months ended March 31,
2022, an increase of $96
million, or 23%, compared to the same period in 2021. The
increase was primarily due to a 29% increase in average local
currency selling prices, which we implemented to recover higher
costs of energy, raw materials, and shipping, and a 1% favorable
impact of mix and other, partially offset by a 6% unfavorable
impact from foreign currency translation, primarily as a result of
the Euro weakening against the U.S. Dollar, and a 1% decrease in
sales volumes compared to the same period in the prior year.
Adjusted EBITDA for the Titanium Dioxide segment was
$49 million for the three months
ended March 31, 2022, an increase of
$9 million, or 23%, compared to the
same period in 2021. The increase was primarily attributable to the
increase in average selling price outpacing our increase in costs
of raw materials, energy, and shipping.
Performance Additives
The Performance Additives
segment generated revenues of $149
million for the three months ended March 31, 2022, an increase of $10 million, or 7%, compared to the same period
in 2021. The increase primarily resulted from a 20% increase in
average local currency selling price, which we implemented to
recover higher costs of energy, raw materials and shipping, and a
1% increase in mix and other, partially offset by a 5% decrease in
sales volumes, primarily driven by decreases in volumes in our
functional additives and timber treatment businesses, and a 4%
unfavorable impact from foreign currency translation primarily as a
result of the Euro weakening against the U.S. Dollar. In addition,
5% of the decrease was due to lost revenue from our water
treatment business, which we sold in the second quarter of 2021 and
which accounted for approximately $6
million of revenue in the first quarter of 2021.
Adjusted EBITDA for the Performance Additives segment was
$20 million for the three months
ended March 31, 2022, a decrease of
$3 million, or 13% compared to the
same period in 2021. The decrease in adjusted EBITDA was primarily
related to higher raw materials, energy and shipping costs,
partially in excess of our increases in average selling price.
Corporate and other
Corporate and other represents expenses which are not allocated
to our segments. Losses from Corporate and other were $12 million in the three months ended
March 31, 2022 or $2 million lower than the same period in 2021.
The decrease was primarily as a result of a reduction in general
and administrative expense and the favorable impact of foreign
exchange rates.
Tax Items
We recorded income tax expense of nil and
$5 million for the three months ended
March 31, 2022 and March 31,
2021, respectively. Our adjusted effective tax rate was 35%
for both the three months ended March 31, 2022 and the same
period in 2021.
Our income taxes are significantly affected by the mix of income
and losses in the tax jurisdictions and valuation allowances in
certain jurisdictions in which we operate. In 2022, we expect to
see an adjusted effective tax rate of approximately 35%. We
continue to expect our adjusted effective tax rate in the long-term
will be approximately 15% to 20%.
Liquidity and Capital Resources
As of March
31, 2022, we had $284 million of total liquidity,
including cash and cash equivalents of $46
million (excluding cash received in the Tronox settlement)
and $238 million of availability under our existing
asset-based revolving credit facility. At the end of the first
quarter, net debt was $908 million
compared to $798 million as of
December 31, 2021.
On April 25, 2022 we received
$85 million cash in settlement with
Tronox to resolve a multi-year legal dispute. We intend to utilize
a portion of these proceeds to reduce our debt.
Primary working capital was a cash use of $87 million in the first quarter 2022. This was
attributable to higher accounts receivables resulting from
increased seasonal sales volumes and higher average selling
prices.
Year to date, capital expenditures totaled $17 million. We expect total capital expenditures
in 2022 to be approximately $85 to
$95 million.
Earnings Conference Call Information
We will hold a conference call to discuss our first quarter 2022
results on Wednesday, May 4, 2022 at 8:00 a.m. ET.
Call-in numbers for the
conference call:
|
|
U.S.
participants
|
1-833-366-1118
|
International
participants
|
1-412-902-6770
|
(No passcode
required)
|
|
In order to facilitate the registration process, you may use the
following link to pre-register for the conference call. Callers who
pre-register will be given a unique PIN and separate call-in number
to gain immediate access to the call and bypass the live operator.
To pre-register, please go to:
https://dpregister.com/sreg/10164613/f1fb2d8f83
Webcast Information
The conference call will be
available via webcast and can be accessed from the company's
website at venatorcorp.com/investor-relations.
Replay Information
The conference call will be
available for replay beginning May 4, 2022 and ending
May 11, 2022.
Call-in numbers for the
replay:
|
|
U.S.
participants
|
1-877-344-7529
|
International
participants
|
1-412-317-0088
|
Passcode
|
2608292
|
Upcoming Conferences
During the second quarter of 2022, a member of management
is expected to present at Deutsche Bank's 13th Annual Global
Materials Conference on June 8, 2022
and BMO's Chemical and Packaging Summit on June 22, 2022. A webcast of the presentations, if
applicable, along with accompanying materials will be available at
venatorcorp.com/investor-relations.
Table 1 — Results of
Operations
|
|
|
|
Three months
ended
|
|
|
March
31,
|
(In millions, except per share amounts)
|
|
2022
|
|
2021
|
Revenues
|
|
$
659
|
|
$
553
|
Cost of goods
sold
|
|
596
|
|
500
|
Operating
expenses
|
|
42
|
|
44
|
Restructuring,
impairment and plant closing and transition costs
|
|
11
|
|
14
|
Operating income
(loss)
|
|
10
|
|
(5)
|
Interest expense,
net
|
|
(15)
|
|
(15)
|
Other income,
net
|
|
3
|
|
5
|
Loss before income
taxes
|
|
(2)
|
|
(15)
|
Income tax
expense
|
|
—
|
|
(5)
|
Net
loss
|
|
(2)
|
|
(20)
|
Net income attributable
to noncontrolling interests
|
|
(1)
|
|
(1)
|
Net loss
attributable to Venator
|
|
$
(3)
|
|
$
(21)
|
|
|
|
|
|
Adjusted
EBITDA(1)
|
|
$
57
|
|
$
49
|
Adjusted net income
attributable to Venator(1)
|
|
$
6
|
|
$
1
|
|
|
|
|
|
Basic loss per
share
|
|
$
(0.03)
|
|
$
(0.20)
|
Diluted loss per
share(4)
|
|
$
(0.03)
|
|
$
(0.20)
|
Adjusted earnings
per share(1)
|
|
$
0.06
|
|
$
0.01
|
Adjusted diluted
earnings per share(1)
|
|
$
0.06
|
|
$
0.01
|
|
|
|
|
|
Ordinary share
information:
|
|
|
|
|
Basic
shares outstanding
|
|
107.6
|
|
107.1
|
Diluted
shares(4)
|
|
107.7
|
|
107.7
|
|
|
|
|
|
See end of press
release for footnote explanations
|
Table 2 — Results of
Operations by Segment
|
|
|
|
|
|
|
|
Three months
ended
|
|
|
|
|
March
31,
|
|
Favorable
/
|
(In millions)
|
|
2022
|
|
2021
|
|
(Unfavorable)
|
Segment
Revenues:
|
|
|
|
|
|
|
Titanium
Dioxide
|
|
$
510
|
|
$
414
|
|
23%
|
Performance
Additives
|
|
149
|
|
139
|
|
7%
|
Total
|
|
$
659
|
|
$
553
|
|
19%
|
|
|
|
|
|
|
|
Segment Adjusted
EBITDA(1):
|
|
|
|
|
|
|
Titanium
Dioxide
|
|
$
49
|
|
$
40
|
|
23%
|
Performance
Additives
|
|
20
|
|
23
|
|
(13)%
|
Corporate and
other
|
|
(12)
|
|
(14)
|
|
14%
|
Total
|
|
$
57
|
|
$
49
|
|
16%
|
|
See end of press
release for footnote explanations
|
Table 3 — Factors
Impacting Sales Revenue
|
|
|
Three months
ended
|
|
March 31, 2022 vs.
2021
|
|
Average Selling Price(a)
|
|
|
|
|
|
|
|
|
|
Local
Currency
|
|
Exchange
Rate
|
|
Sales Mix
& Other
|
|
Sales
Volume(b)
|
|
Divestitures
(c)
|
|
Total
|
Titanium
Dioxide
|
29%
|
|
(6)%
|
|
1%
|
|
(1)%
|
|
—%
|
|
23%
|
Performance
Additives
|
20%
|
|
(4)%
|
|
1%
|
|
(5)%
|
|
(5)%
|
|
7%
|
Total
Company
|
27%
|
|
(6)%
|
|
1%
|
|
(2)%
|
|
(1)%
|
|
19%
|
|
|
(a)
|
Excludes revenues from
tolling arrangements, by-products and raw materials
|
(b)
|
Excludes sales volumes
of by-products and raw materials
|
(c)
|
Our water treatment
business was disposed of in the second quarter of 2021
|
Table 4 —
Reconciliation of U.S. GAAP to Non-GAAP Measures
|
|
|
|
EBITDA
|
|
Net Income
(Loss)
|
|
Diluted Earnings
(Loss) Per
Share(1)(4)
|
|
|
Three months
ended
|
|
Three months
ended
|
|
Three months
ended
|
|
|
March
31,
|
|
March
31,
|
|
March
31,
|
(In millions, except per share amounts)
|
|
2022
|
|
2021
|
|
2022
|
|
2021
|
|
2022
|
|
2021
|
Net
loss
|
|
$ (2)
|
|
$
(20)
|
|
$ (2)
|
|
$
(20)
|
|
$
(0.02)
|
|
$
(0.18)
|
Net income attributable
to noncontrolling interests
|
|
(1)
|
|
(1)
|
|
(1)
|
|
(1)
|
|
(0.01)
|
|
(0.02)
|
Net loss
attributable to Venator
|
|
(3)
|
|
(21)
|
|
(3)
|
|
(21)
|
|
(0.03)
|
|
(0.19)
|
Interest expense,
net
|
|
15
|
|
15
|
|
|
|
|
|
|
|
|
Income tax
expense
|
|
—
|
|
5
|
|
|
|
|
|
|
|
|
Depreciation and
amortization
|
|
31
|
|
31
|
|
|
|
|
|
|
|
|
(Gain) loss on disposal
of businesses/assets
|
|
(1)
|
|
—
|
|
(1)
|
|
—
|
|
(0.01)
|
|
—
|
Certain legal
expenses/settlements
|
|
2
|
|
1
|
|
2
|
|
1
|
|
0.02
|
|
0.01
|
Amortization of pension
and postretirement actuarial losses
|
|
—
|
|
3
|
|
—
|
|
3
|
|
—
|
|
0.03
|
Net plant incident
costs
|
|
2
|
|
1
|
|
2
|
|
1
|
|
0.02
|
|
0.01
|
Restructuring,
impairment, plant closing and transition costs
|
|
11
|
|
14
|
|
11
|
|
14
|
|
0.10
|
|
0.13
|
Income tax
adjustments(2)
|
|
—
|
|
—
|
|
(5)
|
|
3
|
|
(0.05)
|
|
0.03
|
Adjusted(1)
|
|
$ 57
|
|
$ 49
|
|
$ 6
|
|
$ 1
|
|
$
0.06
|
|
$
0.01
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted income tax
expense(2)
|
|
|
|
|
|
$ 5
|
|
$ 2
|
|
|
|
|
Net income attributable
to noncontrolling interests, net of tax
|
|
|
|
|
|
1
|
|
1
|
|
|
|
|
Adjusted pre-tax
income (loss)
|
|
|
|
|
|
$ 12
|
|
$ 4
|
|
|
|
|
Adjusted effective
tax rate
|
|
|
|
|
|
35%
|
|
35%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EBITDA
|
|
Net Income
(Loss)
|
|
Diluted
Earnings (Loss)
Per Share(1)
|
|
|
Three months
ended
December 31,
|
|
Three months
ended
December 31,
|
|
Three months
ended
December 31,
|
(In millions, except per share amounts)
|
|
2021
|
|
2021
|
|
2021
|
Net
loss
|
|
$
15
|
|
$
15
|
|
$
0.14
|
Net income attributable
to noncontrolling interests
|
|
(1)
|
|
(1)
|
|
(0.01)
|
Net loss
attributable to Venator
|
|
14
|
|
14
|
|
0.13
|
Interest expense,
net
|
|
15
|
|
|
|
|
Income tax
expense
|
|
(45)
|
|
|
|
|
Depreciation and
amortization
|
|
30
|
|
|
|
|
Business acquisition
and integration expenses
|
|
1
|
|
1
|
|
0.01
|
Separation
gain
|
|
3
|
|
3
|
|
0.03
|
Loss on disposal of
businesses/assets
|
|
7
|
|
7
|
|
0.07
|
Certain legal
expenses/settlements
|
|
1
|
|
1
|
|
0.01
|
Amortization of pension
and postretirement actuarial losses
|
|
2
|
|
2
|
|
0.02
|
Net plant incident
costs
|
|
4
|
|
4
|
|
0.04
|
Restructuring,
impairment, plant closing and transition costs
|
|
8
|
|
8
|
|
0.07
|
Income tax
adjustments(2)
|
|
—
|
|
(45)
|
|
(0.42)
|
Adjusted(1)
|
|
$
40
|
|
$
(5)
|
|
$
(0.05)
|
|
|
|
|
|
|
|
Adjusted income tax
expense(2)
|
|
|
|
$
—
|
|
|
Net income attributable
to noncontrolling interests, net of tax
|
|
|
|
1
|
|
|
Adjusted pre-tax
loss
|
|
|
|
$
(4)
|
|
|
Adjusted effective
tax rate
|
|
|
|
35 %
|
|
|
|
See end of press
release for footnote explanations
|
Table 5 — Selected
Balance Sheet Items
|
|
|
|
March
31,
|
|
December
31,
|
(In millions)
|
|
2022
|
|
2021
|
Cash and cash
equivalents
|
|
$
46
|
|
$
156
|
Accounts and notes
receivable, net
|
|
489
|
|
371
|
Inventories
|
|
473
|
|
478
|
Prepaid expenses and
other current assets
|
|
89
|
|
84
|
Property, plant and
equipment, net
|
|
816
|
|
848
|
Other assets
|
|
427
|
|
427
|
Total
assets
|
|
$
2,340
|
|
$
2,364
|
|
|
|
|
|
Accounts
payable
|
|
$
401
|
|
$
377
|
Other current
liabilities
|
|
112
|
|
131
|
Current portion of
debt
|
|
5
|
|
5
|
Long-term
debt
|
|
949
|
|
949
|
Non-current payable to
affiliates
|
|
21
|
|
21
|
Other non-current
liabilities
|
|
306
|
|
313
|
Total equity
|
|
546
|
|
568
|
Total liabilities
and equity
|
|
$
2,340
|
|
$
2,364
|
Table 6 —
Outstanding Debt
|
|
|
|
March
31,
|
|
December
31,
|
(In millions)
|
|
2022
|
|
2021
|
Debt:
|
|
|
|
|
Term Loan
Facility
|
|
$
355
|
|
$
356
|
Senior Secured
Notes
|
|
218
|
|
217
|
Senior Unsecured
Notes
|
|
372
|
|
372
|
Other debt
|
|
9
|
|
9
|
Total debt -
excluding affiliates
|
|
954
|
|
954
|
Total cash
|
|
46
|
|
156
|
Net debt - excluding
affiliates
|
|
$
908
|
|
$
798
|
Table 7 — Summarized
Statement of Cash Flows
|
|
|
|
Three months
ended
|
|
|
March
31,
|
(In millions)
|
|
2022
|
|
2021
|
Total cash at
beginning of period
|
|
$ 156
|
|
$ 220
|
Net cash
provided by operating activities
|
|
(86)
|
|
(15)
|
Net cash
(used in) provided by investing activities
|
|
(21)
|
|
(15)
|
Net cash
provided by (used in) financing activities
|
|
(3)
|
|
(2)
|
Effect of
exchange rate changes on cash
|
|
—
|
|
(1)
|
Total cash at end of
period
|
|
$ 46
|
|
$ 187
|
|
|
|
|
|
Supplemental cash
flow information:
|
|
|
|
|
Cash paid
for interest
|
|
$ (25)
|
|
$ (28)
|
Cash paid
for income taxes
|
|
(1)
|
|
—
|
Capital
expenditures
|
|
(17)
|
|
(12)
|
Depreciation and amortization
|
|
31
|
|
31
|
Restructuring
|
|
(11)
|
|
(3)
|
Net cash
flows associated with Pori
|
|
(10)
|
|
(4)
|
|
|
|
|
|
Changes in primary
working capital:
|
|
|
|
|
Accounts
receivable
|
|
(122)
|
|
(50)
|
Inventories
|
|
(1)
|
|
(7)
|
Accounts
payable
|
|
36
|
|
47
|
Total cash provided by (used in) primary working
capital
|
|
$ (87)
|
|
$ (10)
|
|
|
|
|
|
Three months ended
|
|
|
March 31,
|
(In millions)
|
|
2022
|
|
2021
|
Free cash flow(3):
|
|
|
|
|
Net cash
(used in) operating activities
|
|
$ (86)
|
|
$ (15)
|
Capital
expenditures
|
|
(17)
|
|
(12)
|
Free cash
flow(3)
|
|
$
(103)
|
|
$ (27)
|
|
See end of press
release for numbered footnote explanations
|
Footnotes
|
|
(1)
|
Our management uses
adjusted EBITDA to assess financial performance. Adjusted EBITDA is
defined as net income/loss before interest income/expense, net,
income tax expense/benefit, depreciation and amortization, and net
income attributable to noncontrolling interests, as well as
eliminating the following adjustments: (a) business acquisition and
integration expense/adjustments; (b) loss/gain on disposition of
businesses/assets; (c) certain legal expenses/settlements; (d)
amortization of pension and postretirement actuarial losses/gains;
(e) net plant incident costs/credits; and (f) restructuring,
impairment, and plant closing and transition costs/credits. We
believe that net income is the performance measure calculated and
presented in accordance with U.S. GAAP that is most directly
comparable to adjusted EBITDA.
|
|
|
|
We believe adjusted
EBITDA is useful to investors in assessing our ongoing financial
performance and provides improved comparability between periods
through the exclusion of certain items that management believes are
not indicative of our operational profitability and that may
obscure underlying business results and trends. However, this
measure should not be considered in isolation or viewed as a
substitute for net income or other measures of performance
determined in accordance with U.S. GAAP. Moreover, adjusted EBITDA
as used herein is not necessarily comparable to other similarly
titled measures of other companies due to potential inconsistencies
in the methods of calculation. Our management believes this measure
is useful to compare general operating performance from period to
period and to make certain related management decisions. Adjusted
EBITDA is also used by securities analysts, lenders and others in
their evaluation of different companies because it excludes certain
items that can vary widely across different industries or among
companies within the same industry. For example, interest expense
can be highly dependent on a company's capital structure, debt
levels and credit ratings. Therefore, the impact of interest
expense on earnings can vary significantly among companies. In
addition, the tax positions of companies can vary because of their
differing abilities to take advantage of tax benefits and because
of the tax policies of the various jurisdictions in which they
operate. As a result, effective tax rates and tax expense can vary
considerably among companies. Finally, companies employ productive
assets of different ages and utilize different methods of acquiring
and depreciating such assets. This can result in considerable
variability in the relative costs of productive assets and the
depreciation and amortization expense among companies.
|
|
|
|
Nevertheless, our
management recognizes that there are limitations associated with
the use of adjusted EBITDA in the evaluation of us as compared to
net income. Our management compensates for the limitations of using
adjusted EBITDA by using this measure to supplement U.S. GAAP
results to provide a more complete understanding of the factors and
trends affecting the business rather than U.S. GAAP results
alone.
|
|
|
|
In addition to the
limitations noted above, adjusted EBITDA excludes items that may be
recurring in nature and should not be disregarded in the evaluation
of performance. However, we believe it is useful to exclude such
items to provide a supplemental analysis of current results and
trends compared to other periods because certain excluded items can
vary significantly depending on specific underlying transactions or
events, and the variability of such items may not relate
specifically to ongoing operating results or trends and certain
excluded items, while potentially recurring in future periods, may
not be indicative of future results.
|
|
|
|
Adjusted net income
(loss) attributable to Venator Materials PLC ordinary shareholders
is computed by eliminating the after-tax amounts related to the
following from net income/loss attributable to Venator Materials
PLC ordinary shareholders: (a) business acquisition and integration
expenses/adjustments; (b) loss/gain on disposition of
businesses/assets; (c) certain legal expenses/settlements; (d)
amortization of pension and postretirement actuarial losses/gains;
(e) net plant incident costs/credits; and (f) restructuring,
impairment, and plant closing and transition costs/credits. Basic
adjusted net income per share excludes dilution and is computed by
dividing adjusted net income by the weighted average number of
shares outstanding during the period. Adjusted diluted net income
per share reflects all potential dilutive ordinary shares
outstanding during the period increased by the number of additional
shares that would have been outstanding as dilutive
securities.
|
|
|
|
Adjusted net income
(loss) and adjusted net income (loss) per share amounts are
presented solely as supplemental information. These measures
exclude similar noncash items as adjusted EBITDA in order to assist
our investors in comparing our performance from period to period
and as such, bear similar risks as adjusted EBITDA as documented
above. For that reason, adjusted net income and the related per
share amounts, should not be considered in isolation and should be
considered only to supplement analysis of U.S. GAAP
results.
|
|
|
(2)
|
Income tax expense is
adjusted by the amount of additional tax expense or benefit that we
would accrue if we used non-GAAP results instead of GAAP results in
the calculation of our tax liability, taking into consideration our
tax structure. We use a normalized effective tax rate of 35%, which
reflects the weighted average tax rate applicable under the various
jurisdictions in which we operate. This non-GAAP tax rate
eliminates the effects of non-recurring and period specific items
which are often attributable to restructuring and acquisition
decisions and can vary in size and frequency. This rate is subject
to change over time for various reasons, including changes in the
geographic business mix, valuation allowances, and changes in
statutory tax rates.
|
|
|
|
We eliminate the effect
of significant changes to income tax valuation allowances from our
presentation of adjusted net income to allow investors to better
compare our ongoing financial performance from period to period. We
do not adjust for insignificant changes in tax valuation allowances
because we do not believe it provides more meaningful information
than is provided under GAAP. We believe that our revised approach
enables a clearer understanding of the long-term impact of our tax
structure on post tax earnings.
|
|
|
(3)
|
Management internally
uses a free cash flow measure: (a) to evaluate the Company's
liquidity, (b) to evaluate strategic investments, (c) to evaluate
the Company's ability to incur and service debt. Free cash flow is
not a defined term under U.S. GAAP, and it should not be inferred
that the entire free cash flow amount is available for
discretionary expenditures. Free cash flow is defined as cash flows
provided by (used in) operating activities from continuing
operations less capital expenditures. The Company updated its
definition of free cash flow during the third quarter of 2021 to
conform to the definition more commonly used by publicly traded
companies. Prior to the third quarter of 2021, free cash flow was
defined as cash flows provided by (used in) operating activities
from continuing operations and used in investing activities. Prior
period comparatives within this release have been restated for the
updated definition. Free cash flow is typically derived directly
from the Company's consolidated statement of cash flows; however,
it may be adjusted for items that affect comparability between
periods. Free cash flow is presented as supplemental
information.
|
|
|
(4)
|
The potentially
dilutive impact of share-based awards was excluded from the
calculation of earnings per share for the three months ended March
31, 2022 because there is an anti-dilutive effect as we are in a
net loss position.
|
|
|
(5)
|
"Net debt" is not a
defined term under U.S. GAAP. We define net debt as debt (the most
comparable GAAP measure, calculated as long-term obligations plus
short-term borrowings) minus cash and cash equivalents. Management
believes that net debt is an important measure to monitor leverage
and evaluate the balance sheet.
|
About Venator
Venator is a global manufacturer and
marketer of chemical products that comprise a broad range of
pigments and additives that bring color and vibrancy to buildings,
protect and extend product life, and reduce energy consumption. We
market our products globally to a diversified group of industrial
customers through two segments: Titanium Dioxide, which consists of
our TiO2 business, and Performance Additives, which
consists of our functional additives, color pigments and timber
treatment businesses. Based in Wynyard, U.K., Venator employs approximately
3,500 associates and sells its products in more than 110
countries.
Social Media:
Twitter: www.twitter.com/VenatorCorp
Facebook: www.facebook.com/venatorcorp
LinkedIn: www.linkedin.com/company/venator-corp
Cautionary Statement Concerning Forward-Looking
Statements
Certain statements contained in this press
release constitute "forward-looking statements" within the meaning
of the U.S. Private Securities Litigation Reform Act of 1995. These
forward- looking statements represent Venator's expectations or
beliefs concerning future events, and it is possible that the
expected results described in this press release will not be
achieved. These forward looking statements are subject to risks,
uncertainties and other factors, many of which are outside of
Venator's control, that could cause actual results to differ
materially from the results discussed in the forward looking
statements, including the impacts and duration of the global
outbreak of the COVID-19 pandemic on the global economy and all
aspects of our business, including our employees, customers,
suppliers, partners, results of operations, financial condition and
liquidity, global economic conditions, our ability to maintain
sufficient working capital, our ability to access capital markets
on favorable terms, the costs associated with the closure of our
Pori facility and execution of our business improvement programs
and initiatives, our ability to realize financial and operational
benefits from our business improvement plans and initiatives,
changes in raw material and energy prices, interruptions in raw
materials and energy, industry production capacity and operating
rates, the supply demand balance for our products and that of
competing products, pricing pressures, technological developments,
legal claims by or against us, changes in government regulations,
including increased manufacturing, labeling and waste disposal
regulations and the classification of TiO2 as a
carcinogen in the EU, management of materials resulting from our
manufacturing process, including the ability to develop
commercial markets in the regions that we manufacture and our
ability to dispose of these materials if necessary, the impacts of
increasing climate change regulations, geopolitical events,
cyberattacks and public health crises.
Any forward-looking statement speaks only as of the date on
which it is made, and, except as required by law, Venator does not
undertake any obligation to update or revise any forward-looking
statement, whether as a result of new information, future events or
otherwise. New factors emerge from time to time, and it is not
possible for Venator to predict all such factors. When considering
these forward looking statements, you should keep in mind the risk
factors and other cautionary statements in Venator's filings with
the US Securities and Exchange Commission, including Venator's
Annual Reports on Form 20-F for the year ended December 31, 2021 and its Quarterly Report on
Form Form 6-K for the quarter ended March
31, 2022. The risk factors and other factors noted therein
could cause its actual results to differ materially from those
contained in any forward looking statement.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/venator-announces-first-quarter-2022-results-successful-selling-price-initiatives-mitigate-inflationary-costs-301539345.html
SOURCE Venator Materials PLC